MAUDE Adverse Event Report: TORAX MEDICAL, INC. 1.5T LINX, 17 BEADS; ANTI-REFLUX IMPLANT

Catalog Number	LXMC17
Medical Device Problem Code	Device Appears to Trigger Rejection (1524)
Health Effect - Clinical Code	Dysphagia/ Odynophagia (1815)
Date of Event	04/18/2023
Type of Reportable Event	Serious Injury
Event or Problem Description
It was reported via clinical trial patient (b)(6) experience, dysphagia.Relationship to study device: possible.
Additional Manufacturer Narrative
(b)(4).Date sent: 4/18/2024.Lot number was received and dhr is pending review.When the review is completed, a supplemental medwatch will be sent with a summary of the evaluation.Additional information received: start date: (b)(6) 2023; alert date: (b)(6) 2024; country of event: us; model: lxmc17; device lot number: 26632; date of surgery: (b)(6) 2021 adverse event term: dysphagia.Patient details.Patient identifier: (b)(6).Sex: female.Age (at time of consent): 53 years.Additional event details.Site awareness date: 10 may 2023; end date: (b)(6) 2024 severity: mild is the adverse event serious? no; death: no; date of death: blank.Life-threatening illness or injury: no.Permanent impairment of a body structure or a body function: no required in-patient hospitalization or prolongation of existing hospitalization: no admission date: blank discharge date: blank resulted in medical or surgical intervention: no led to fetal distress, fetal death or a congenital abnormality or birth defect: no relationship to study device: possible relationship to primary study procedure: possible if related to the procedure, indicate which procedure the event is related to: blank intervention/treatment: none: no.Dilation performed: yes.Indicate type of dilation? mechanical; date of dilation: (b)(6) 2023; diagnostic intervention: no; diagnostic imaging: yes; drug therapy: no; observation: no; linx explant: no; other surgical intervention: no; other intervention/treatment: no; if other specify: blank; outcome: recovered/resolved.According to the protocol and instructions for use, in the opinion of the investigator, is the adverse event expected/anticipated: blank did this event result in the patient¿s discontinuation of the study? no.Log line 1 updated.If event is serious and device related, according to the protocol and instructions for use, in the opinion of the investigator, is the adverse event expected/anticipated? : blank => no.Serious adverse event: no; relationship to study device: possible; relationship to primary study procedure: possible; dilation performed: yes; drug therapy: no; serious adverse event: no; relationship to study device: possible; relationship to primary study procedure: possible; dilation performed: yes; drug therapy: no.Updated: if event is serious and device related, according to the protocol and instructions for use, in the opinion of the investigator, is the adverse event expected/anticipated? : blank => no.Awareness date : 10 may 2023 => 16 apr 2024.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
Additional Manufacturer Narrative
(b)(4).Date sent: 5/9/2024.A manufacturing record evaluation was performed for the finished device 26632 number, and no non-conformances related to the malfunction were identified.
Additional Manufacturer Narrative
(b)(4).Date sent: 8/18/2025.Additional information: updated: severity: mild = moderate.

• Brand Name: 1.5T LINX, 17 BEADS
• Common Device Name: ANTI-REFLUX IMPLANT
• Manufacturer (Section D): TORAX MEDICAL, INC.; 4545 creek road; cincinnati OH
• Manufacturer Contact: kate karberg ; 4545 creek rd.; cincinnati, OH 45242 ; 3035526892
• MDR Report Key: 19137864
• Report Number: 3008766073-2024-00067
• Device Sequence Number: 13121216
• Product Code: LEI
• UDI-Device Identifier: 00855106005370
• UDI-Public: 00855106005370
• Combination Product (Y/N): N
• Initial Reporter Country: US
• PMA/510(K) Number: P100049
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2021
• Serviced by Third Party (Y/N): Unknown
• Reporter Type: Manufacturer
• Report Source: Company Representative
• Initial Reporter Occupation: Other
• Type of Report: Initial,Followup,Followup
• Report Date (Section B): 08/18/2025

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Expiration Date: 02/07/2024
• Device Catalogue Number: LXMC17
• Device Lot Number: 26632
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: No
• Type of Report(Section G): Follow-Up
• Initial Date Received by Manufacturer: 04/16/2024
• Supplement Date Received by Manufacturer: 05/09/2024; 08/15/2025
• Initial Report FDA Received Date: 04/18/2024
• Supplement Report FDA Received Date: 05/09/2024; 08/18/2025
• Was Device Evaluated by Manufacturer? (Y/N): Device Not Returned to Manufacturer
• Date Device Manufactured: 02/07/2020
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): Yes
• Usage of Device: Initial
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Age: 53 YR
• Patient Sex: Female